ABBV: AbbVie Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) n/a
Enterprise Value ($M) 171,127.97
Book Value ($M) -7,826.00
Book Value / Share -5.29
Price / Book -18.01
NCAV ($M) n/a
NCAV / Share n/a
Price / NCAV n/a

Profitability (mra)
Return on Invested Capital (ROIC) 0.20
Return on Assets (ROA) 0.08
Return on Equity (ROE) -0.67

Liquidity (mrq)
Quick Ratio 0.91
Current Ratio 1.04

Balance Sheet (mrq) ($M)
Current Assets 14,413.00
Assets 56,769.00
Liabilities 64,595.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 32,753.00
Operating Income 6,383.00
Net Income 5,687.00
Earnings Per Share Diluted 3.66
Earnings Per Share Basic 3.67

Cash Flow Statement (mra) ($M)
Cash From Operations 13,427.00
Cash from Investing -1,006.00
Cash from Financing 13,427.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
2020-02-14 13G/A Capital Research Global Investors 5.80 -8.71
2020-02-12 13G/A Vanguard Group Inc 8.28 1.65
2020-02-05 13G/A BlackRock Inc. 6.70 2.93

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2019-11-06 10-Q ABBV / AbbVie Inc. 10-Q – Quarterly Report – 10-Q
2019-08-05 10-Q ABBV / AbbVie Inc. 10-Q – Quarterly Report – 10-Q
2019-05-03 10-Q ABBV / AbbVie Inc. 10-Q Quarterly Report 10-Q
2019-02-27 10-K ABBV / AbbVie Inc. 10-K (Annual Report)

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2020-02-14 1,146,416 11,175,700 10.26
2020-02-13 1,311,047 10,612,900 12.35
2020-02-12 1,295,822 10,591,000 12.24
2020-02-11 1,303,244 10,682,700 12.20

(click for more detail)

Similar Companies
ABT – Abbott Laboratories AGN – Allergan plc


Financial data and stock pages provided by
Fintel.io